The approach, published April 8 in Immunity, exploits the immune system's built-in safety mechanism—a group of regulatory T cells whose job is to squelch overactive immune responses.
Therefore, the effective measures are to increase vaccination rate and immunity of the specific group, decrease the susceptible population and intensify epidemic monitoring.